Our website uses cookies to give you the best and most relevant experience. By clicking on accept, you give your consent to the use of cookies as per our privacy policy.AcceptDeny

July 1905

Case report: effect of umbilical cord mesenchymal stem cells on immunoglobulin A nephropathy after acute renal failure

Journal Citation

Am J Transl Res. 2022; 14(7): 4855–4859

Authors

NH Riordan, RA Ambrozic, J Paz-Rodríguez.

Abstract

Immunoglobulin A nephropathy is an inflammatory, autoimmune condition that may lead to renal impairment in its most aggressive forms. In this case report, a 50-year-old male with acute renal failure was diagnosed with IgA nephropathy, having elevated creatinine levels (3.0 mg/dL) and hypertension. He received intravenous infusions of a total of 120 million umbilical cord-derived mesenchymal stem cells (UC-MSCs) and was followed-up for 6 months. No adverse events were reported during or after administration or any of the follow-up visits. Creatinine levels decreased to and remained normal (1.0 mg/dL) in the 6 months following treatment. Anti-hypertensive medications were no longer needed. UC-MSC administration was safe, well-tolerated, and beneficial for this patient with IgA nephropathy.

Embrace your opportunity for a brighter future today.